Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829489 · ClinicalTrials.gov registry record
International Nutrition Audit in FORegut TuMors
A clinical trial, sponsored by University of Alberta.
- Completed
- Registry status
- 170
- Enrollment target
NCT02829489: Completed study, sponsored by University of Alberta.
NCT02829489 is a clinical trial that has completed, run by University of Alberta. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02829489 has completed, sponsored by University of Alberta.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the current state of nutrition care and patient related outcomes in patients with head, neck and esophageal cancers in North America, Europe and Australia.
Primary Outcome
What is the timing of start of nutrition, adequacy of nutrition and the route of nutrition (oral, enteral and/or parenteral)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2016-07-26 |
| Est. Completion | 2019-10-15 |
What the finished NCT02829489 record still lists
NCT02829489 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02829489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02829489 about?
NCT02829489 is a clinical study titled "International Nutrition Audit in FORegut TuMors". The purpose of this study is to evaluate the current state of nutrition care and patient related outcomes in patients with head, neck and esophageal cancers in North America, Europe and Australia.
What is the current status of trial NCT02829489?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2016-07-26. Estimated completion is 2019-10-15.
Who is sponsoring clinical trial NCT02829489?
This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI